Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: To investigate the potential clinical benefits of mid-urethral sling (MUS) and urethral dilatation (UD) operations for the treatment of stress urinary incontinence (SUI) combined with urethral stricture.
Study Design: Descriptive study. Place and Duration of the Study: Department of Urology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China, from January 2017 to 2022.
Methodology: Patients with Qmax <15ml/s or PVR >50ml, and video urodynamic study (VUDS) capable of confirming the presence and position of urethral stricture were included. The clinical efficacy was evaluated by International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) questionnaire, maximum flow rate (Qmax), and postvoid residual (PVR) urine. ICIQ-SF, Qmax, and PVR were measured presurgery, on postoperative 2-week, and 1-month postsurgery.
Results: There were total 19 patients with an average age of 61.37 ± 11.28 years (range 39-84) with SUI and urethral stricture. ICIQ-SF scores were decreased significantly at one month postoperatively compared with the preoperative [5.0 (0.0, 7.0) vs. 14.0 (13.0, 15.0), p <0.001]. Qmax was increased dramatically compared with the preoperative [21.3 (14.0, 28.4) vs. 13.0 (8.7,18.0), p <0.001], and PVR was decreased remarkably than the preoperative [0.0 (0.0,0.0) vs. 0.0 (0.0,60.0), p = 0.018]. Of 19 patients primarily managed with MUS and UD, two patients experienced recurrence requiring repetitive dilation till sling excision surgery was conducted, and improvement was evident in one patient after repeating UD.
Conclusion: The overall incidence of SUI combined with urethral stricture in women is low. With a success rate of 89.5%, MUS and UD were effective therapies for the co-existence of SUI with urethral stricture, and repeated UD can be performed safely if necessary in long-term follow-up.
Key Words: Stress urinary incontinence, Urethral stricture, Mid-urethral sling, Urethral dilatation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.29271/jcpsp.2024.06.702 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Analysis of transurethral water vapor thermal therapy for the treatment of benign prostatic hyperplasia].
Zhonghua Nan Ke Xue
July 2025
Department of Urology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, Jiangsu, China.
Objective: To investigate the efficacy and safety of transurethral water vapor thermal therapy (WVTT) using the Rezūm system for benign prostatic hyperplasia (BPH) in the real world.
Methods: A total of 181 patients with BPH were recruited from the Second Affiliated Hospital of Nanjing Medical University from August 2022 to December 2023, of whom 173 patients were treated with WVTT using the Rezūm system, while 8 patients were treated with WVTT combined with TURP. They were followed up at 1, 3, and 6 months postoperatively to assess changes in the IPSS, QoL, Qmax, IIEF-5, and the occurrence of any complications.
How I do it: percutaneous cystolitholapaxy for bladder stones with complex lower urinary tract anatomy.
Can J Urol
August 2025
Department of Urology, Mayo Clinic, Rochester, MN 55905, USA.
While cystolitholapaxy for bladder stones is commonly performed using a transurethral approach, large or complex stone burdens in patients with complex lower urinary tract anatomy may make this inefficient or infeasible. Percutaneous cystolitholapaxy is a safe, effective, minimally invasive alternative for diverse indications, including patients with benign prostatic hyperplasia, urethral stricture disease, closed bladder neck, continent catheterized channel, or other urinary diversion. In this article, we review the indications for and advantages of percutaneous cystolitholapaxy and describe our step-by-step technique for this procedure, including representative imaging and favored equipment.
View Article and Find Full Text PDFBioengineered urethral grafts for strictures: a perspective on advancements, functional restoration, and affordability.
Ann Med Surg (Lond)
September 2025
The Maldives National University, Malé, Maldives.
Urethral stricture is a chronic urological condition that remains challenging to manage due to the limitations of traditional treatments like dilation and urethroplasty, which are prone to recurrence and complications. Tissue-engineered urethral grafts have emerged as a promising alternative, offering durable, functional restoration with reduced donor site morbidity. Innovations in scaffold fabrication, especially 3D bioprinting and hydrogel-based bio-inks, have led to the creation of structurally and biologically compatible constructs that can regenerate native urothelial layers.
View Article and Find Full Text PDFMetachronous Bilateral Nephrectomy, Supratrigonal Cystectomy, and Living Donor Renal Transplantation in a Patient With Chronic Kidney Disease due to Interstitial Cystitis and Total Urethral Stricture.
Case Rep Med
August 2025
Department of Radiology, Azerbaijan Medical University, Baku, Azerbaijan.
Interstitial cystitis (IC) is a chronic pelvic pain syndrome characterized by urinary urgency, frequency, and pain. Although the exact cause of IC is unclear, severe cases may lead to chronic kidney disease (CKD), requiring complex surgical interventions. This case report presents a 46-year-old male with IC complicated by CKD secondary to total urethral stricture.
View Article and Find Full Text PDFDonor site morbidity and impact on oral health following buccal mucosal graft harvesting for urethroplasty: a prospective study.
World J Urol
September 2025
Department of Urology, Antwerp University Hospital, Antwerp, Belgium.
Purpose: To evaluate patient-reported oral health and pain and buccal donor site complications in adults who underwent BMG harvesting utilizing two validated questionnaires.
Materials And Methods: An ethics-approved prospective observational study was conducted among a cohort of 40 adults who had a BMG urethroplasty between June 2020 and October 2021. All cases were performed by one fellowship-trained genitourinary reconstructive surgeon.